RecruitingNCT05364294
Molecular Diagnosis of Systemic Autoinflammatory Diseases
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment
300 participants
Start Date
May 18, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.
Eligibility
Min Age: 1 WeekMax Age: 120 Years
Inclusion Criteria1
- A patient presenting with a clinical and biological aseptic inflammatory syndrome associating one or more of the following signs: spontaneously resolving fever, abdominal (pain, diarrhea), locomotor (arthralgia, myalgia), thoracic (pain, pericarditis), cutaneous, sensory (uveitis, deafness), or renal (amyloidosis) involvement.
Exclusion Criteria1
- Adult subject to legal protection measures (guardianship, curatorship, safeguard of justice).
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05364294
Related Trials
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
NCT011434543 locations
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
NCT050120331 location
Linking Somatic Mutation Rate With Baseline Exposure in East Palestine
NCT063578451 location
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
NCT0245085133 locations
68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases
NCT062754771 location